Tricida, Inc.

  1. May 19, 2023

    Del. Court Rejects Tricida's Ch. 11 Plan, Citing Unfair Opt-Outs

    A Delaware bankruptcy judge rejected Tricida Inc.'s Chapter 11 plan Friday and ordered the drug developer to remove language that would have prevented shareholders from suing Tricida's creditors or other third parties, finding the process Tricida used to inform the shareholders about the plan was not fair and equitable.

  2. March 24, 2023

    Tricida Heading For Ch. 11 Confirmation Fight With Creditors

    Disputes over releases of claims included in the Chapter 11 plan of drug developer Tricida Inc. have set the stage for a contested plan confirmation hearing, with debtor attorneys saying Friday that it hopes continued mediation with unsecured creditors will resolve the issues.

  3. March 06, 2023

    Tricida Heads To Ch. 11 Mediation Over Creditor Plan Issues

    Drug developer Tricida Inc. asked a Delaware bankruptcy judge Monday to select one of his colleagues on the bench to facilitate mediation of creditor disputes, which the debtor hopes will resolve issues standing in the way of its Chapter 11 plan process.

  4. February 27, 2023

    Release Opt Out Trips Up Tricida Ch. 11 Disclosure Approval

    Drug developer Tricida Inc. failed to receive court approval Monday for its Chapter 11 plan disclosure statement when a Delaware bankruptcy judge said he had concerns about the release of claims through a disfavored opt-out provision that would extinguish the claims of shareholders in pending securities litigation against the company's CEO without any discernible consideration.

  5. February 21, 2023

    Renibus Buys Tricida's Kidney Drug Veverimer In Ch. 11 Sale

    Texas clinical-stage biotechnology company Renibus Therapeutics Inc. will take over the development of Tricida Inc.'s drug candidate for chronic kidney disease and could eventually pay the bankrupt San Francisco-based company up to $152.75 million if Renibus is able to successfully market the drug, Tricida said at a hearing in Delaware on Tuesday.

  6. January 26, 2023

    Tricida Gets OK To Seek Stalking Horse For Ch. 11 Auction

    A Delaware bankruptcy judge Thursday gave San Francisco biotech company Tricida Inc. the go-ahead to look for a stalking horse bidder before it puts its assets on the block next month.

  7. January 13, 2023

    Voyager Sells Digital Assets For $1B, FTX Finds $5B In Crypto

    Cryptocurrency debtors put billions of dollars in play this week as Voyager Digital Holdings got the nod for a $1 billion sale of assets and FTX Trading located $5 billion of its own assets. Over at the U.S. Supreme Court, the justices wrestled with Puerto Rican sovereignty in a case involving the island's fiscal board. This is the week in bankruptcy.

  8. January 13, 2023

    Biotech Co. Tricida Gets Bankruptcy Auction Fast-Tracked

    Bankrupt San Francisco biotech company Tricida Inc. got conditional approval Friday for an expedited sale process in Chapter 11, overcoming skepticism from a Delaware bankruptcy judge and objections from the U.S. Trustee's Office that there were no "compelling circumstances" to justify a fast track.